Delivery Order SPE2DE24D0013-SPE2D626F09YN
- Not listed
- The Defense Logistics Agency Medical Supply Chain has awarded a $2,024 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, designated XPRSTREPA-10, was awarded on December 30, 2025, with an ultimate completion date of January 7, 2026, and carries no set-aside designation. The contract is for performance at Cepheid's Sunnyvale facility and represents a...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, contains no set-aside provisions and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The contract involves the supply of diagnostic reagents and test kits for Cepheid's GeneXpert platform, which...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,400 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on January 8, 2026, for molecular diagnostic supplies under contract XPRS4PLEX-10. This firm fixed-price delivery order, with an ultimate completion date of January 15, 2026, represents a child contract issued from Cepheid's broader Indefinite Delivery Vehicle with the Department of Veterans Affairs. The contract utilizes no set-aside designation and specifies performance at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...
- This delivery order, valued at $1,277.84, was awarded on November 18, 2025, to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. The award is a firm fixed-price delivery order with no set-aside designation, utilizing a Defense Logistics Agency Medical Supply Chain contract vehicle. Based on Cepheid's established federal portfolio, this delivery order likely involves diagnostic testing supplies, reagents, or test...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,815.72 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on June 27, 2025, for completion by July 7, 2025. The delivery order, identified as XPRSMVP-10, will be performed in Sunnyvale, California, and carries no set-aside designation. Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $13.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of October 3, 2025. This delivery order, which carries no set-aside designation, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities and equipment. Cepheid specializes in advanced...
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F09YNDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,843.36 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on January 15, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents a child contract under a larger indefinite delivery vehicle. The work will be performed at Cepheid's headquarters in Sunnyvale, California. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid supplies the Defense Logistics Agency with diagnostic testing supplies, test kits, and reagents that support federal healthcare operations and military medical readiness. This delivery order falls within the scope of Cepheid's extensive federal contracting portfolio, which includes significant prime indefinite delivery contracts with the Department of Veterans Affairs valued at tens of millions of dollars through 2030. The company's core diagnostic platform, GeneXpert, has become a primary solution across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard for rapid molecular testing of infectious diseases including COVID-19, influenza, tuberculosis, and other pathogens. The modest value of this particular delivery order reflects routine procurement activity under the established Defense Logistics Agency contracting relationship that ensures continuous supply of critical diagnostic capabilities to federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/14/26 |